Yamaguchi A, Ishida T, Nishimura G, Kanno M, Kosaka T, Yonemura Y, Miyazaki I
Department of Surgery II, School of Medicine, Kanazawa University.
Nihon Geka Gakkai Zasshi. 1990 Oct;91(10):1591-5.
Nuclear DNA ploidy studies were performed by flow cytometry on extracted nuclei from 65 heptic metastases from colorectal cancer. In 25 patients, both primary and metastatic lesions were available for analysis. Primary carcinomas were DNA diploid pattern in 48.1%, DNA aneuploid in 51.9%. Of 31 hepatic metastases, 11 (35.5%) metastases showed a DNA diploid pattern, and 25 (64.5%) showed a DNA aneuploid pattern. Ploidy pattern was constant between primary and metastases in 80% of tumors. No significant relationship between metastatic characteristics and DNA ploidy pattern was found. The DNA aneuploid cancers had a relatively poorer prognosis in patients with unresectable hepatic metastasis. In resected hepatic metastases from colorectal cancer, rate of hepatic recurrence with DNA diploid pattern was lower than that with DNA aneuploid pattern. Survival of patients with DNA diploid metastases (71% alive at 5 years) was significantly better than that of patients with DNA aneuploid metastases (21% alive at 5 years) (p less than 0.05). These results demonstrated that flow cytometric DNA ploidy measurements may have prognostic value for patients with hepatic metastases from colorectal cancer.
采用流式细胞术对65例结直肠癌肝转移灶提取的细胞核进行核DNA倍体研究。25例患者的原发灶和转移灶均可用于分析。原发癌中,48.1%为DNA二倍体模式,51.9%为DNA非整倍体模式。31个肝转移灶中,11个(35.5%)转移灶显示DNA二倍体模式,25个(64.5%)显示DNA非整倍体模式。80%的肿瘤原发灶和转移灶的倍体模式一致。未发现转移特征与DNA倍体模式之间存在显著关系。在不可切除肝转移患者中,DNA非整倍体癌的预后相对较差。在结直肠癌切除的肝转移灶中,DNA二倍体模式的肝复发率低于DNA非整倍体模式。DNA二倍体转移患者的生存率(5年生存率为71%)显著高于DNA非整倍体转移患者(5年生存率为21%)(p<0.05)。这些结果表明,流式细胞术检测DNA倍体对结直肠癌肝转移患者可能具有预后价值。